PET scans may help predict survival in rare melanoma
NCT ID NCT07506447
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 68 people with a rare type of skin cancer called mucosal melanoma. Researchers used a special PET scan to see if certain imaging details could predict how long patients live or when their cancer might come back. The goal is to help doctors make better treatment choices for each patient.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FDG PET are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wuhan Union Hospital
Wuhan, Hubei, 430022, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an immune checkpoint blocker outperform interferon in keeping mucosal melanoma at bay?
- Triple PET imaging could sharpen epilepsy surgery targeting
- New drug cocktail targets rare, aggressive melanoma
- Can a vaccine keep melanoma from coming back? large trial tests immune boosters
- New drug KUP-101A enters first human tests for advanced skin cancers
- Triple drug attack on melanoma: new trial hopes to boost surgery success